Kyle Farmer

Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease

Kyle Farmer, Catherine A. Smith, Shawn Hayley et al. · International Journal of Molecular Sciences · 2015 · 75 citations · Full text

NADPH oxidase 2 activity in Parkinson's disease

Matthew T. Keeney, Eric K. Hoffman, Kyle Farmer et al. · Neurobiology of Disease · 2022 · 44 citations · Full text

Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration

Zach Dwyer, Chris Rudyk, Ashley Thompson et al. · Neurobiology of Aging · 2020 · 42 citations · Full text

Immunology, Cell Death, Lrrk2 Ablation +20

Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers

Derek M. Foster, Megan E. Jacob, Kyle Farmer et al. · PLoS ONE · 2019 · 38 citations · Full text

Ceftiofur Formulation, Antimicrobial Susceptibility, Antibiotics +15

mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson’s Disease

Kyle Farmer, Khaled S. Abd‐Elrahman, Alexa Derksen et al. · Molecular Neurobiology · 2019 · 36 citations

Neurodegenerative Diseases, Molecular Neuroscience, Medicine +12